Comparing two measurements from each eye helped identify past optic nerve inflammation in people with MS.
Researchers compared measurements from both eyes using scans of the back of the eye. Using two measurements together was better at identifying past optic nerve inflammation than using either measurement alone. This approach missed more affected eyes, but it more often ruled out eyes without past inflammation. A measurement from one part of the eye scan added little benefit. Differences between eyes stayed stable over time, and a second group of people with MS showed similar results.
The study included people with MS who had eye scans. Researchers looked for signs that one optic nerve had been inflamed before. This matters because past optic nerve inflammation can help doctors assess MS. The findings concern how eye scans are read, not a new treatment. The second group came from a different center, which let researchers check whether the findings held up there.
Researchers analyzed eye scans from 1,854 people with MS and checked the findings in another 254 people. You should know this study tested how well scans identified past optic nerve inflammation, not whether they improved care. The abstract does not say how often scan results changed an MS diagnosis.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/7/2026
A 3D-printed immune implant eased advanced MS-like disease in mice without broadly weakening immunit
Read More10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Brain : a journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.